Renal Artery Obstruction
12
1
1
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
16.7%
2 terminated out of 12 trials
75.0%
-11.5% vs benchmark
33%
4 trials in Phase 3/4
67%
4 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
On-table Renal Perfusion Evaluation Renal Artery Stenosis or Obstruction
Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement
Endovascular Therapy for Renal Artery Stenosis in China
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Gadobutrol Enhanced MRA of the Renal Arteries
The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis
Renal Stenting With Distal Atheroembolic Protection
Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery
Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis